Chordate Medical Holding AB (publ) Appoints Lago Kapital as Liquidity Provider

Nyheter Chordate Medical Nyheter alla bolag

Hej Visste du att du med vår premiumtjänst får fullständig historik i alla grafer, pressmeddelanden och andra notiser för dina favoritbolag direkt som DM i Discord samt en del andra godsaker? Du slipper dessutom störande annonser på sajten. Testa gratis i 14 dagar!

Chordate Medical Holding AB (publ) Appoints Lago Kapital as Liquidity Provider

MARKN.

Chordate Medical Holding AB (publ) ("Chordate") has entered into an agreement for liquidity provision with Lago Kapital ("Lago").

According to the agreement, Lago will provide trading posts in Chordate's stock on both the buy and sell sides in accordance with and within the framework of Nasdaq Stockholm's rules for liquidity provision. The purpose of liquidity provision is to improve liquidity and reduce volatility. Lago's assignment commences on April 19th, 2024.

About Chordate
Chordate Medical Holding AB (publ) is a medical technology company that has developed, patented and CE-marked Ozilia® Migraine (formerly K.O.S), a neuromodulation and drug-free treatment technology for chronic migraine and chronic rhinitis. The treatment has clinically proven efficacy according to a recent study, and is marketed in selected markets in the EU and the Middle East. Chordate Medical is listed on Nasdaq First North Growth Market Stockholm (ticker: CMH). Read more at www.chordate.com

The company's Certified Adviser on Nasdaq First North Growth Market Stockholm is Vator Securities AB.

N.B. The English text is an in-house translation of the original Swedish text. Should there be any disparities between the Swedish and the English text, the Swedish text shall prevail.

Datum	2024-04-18, kl 08:30
Källa	MFN

Bifogade filer

Chordate Medical Holding AB (publ) Appoints Lago Kapital as Liquidity Provider

LOGGA IN

Chordate Medical

Chordate Medical Holding AB (publ) Appoints Lago Kapital as Liquidity Provider